Patents Expiring in December 2026
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor | GRANULE;ORAL | 217660-001 | Apr 26, 2023 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF CF IN PATIENTS AGED 2 TO | |||
| Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor | GRANULE;ORAL | 217660-001 | Apr 26, 2023 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF CF IN PATIENTS AGED 2 TO | |||
| Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor | GRANULE;ORAL | 217660-001 | Apr 26, 2023 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF CF WITH ELX/ | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
